Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE (CILPA) (LOCAL NDC06909787067) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 12, 2026 , from http://ppman.hank.ai/transparency/procedure/NDC06909787067/by-state?code_type=LOCAL
“LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE (CILPA) (LOCAL NDC06909787067) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/NDC06909787067/by-state?code_type=LOCAL. Accessed
November 12, 2026 .
“LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE (CILPA) (LOCAL NDC06909787067) by State,” HANK Price Transparency ,
accessed November 12, 2026 ,
http://ppman.hank.ai/transparency/procedure/NDC06909787067/by-state?code_type=LOCAL.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
LOCAL · across United States
NDC06909787067 — Lanreotide 120 Mg/0.5 Ml Subcutaneous Syringe (cilpa)
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$41,404
National median
$16,220 – $62,501
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for NDC06909787067 (LOCAL), with interquartile range
State Median p25 p75
KY $41,404 $16,220 $62,501